mr MATTHEW HOEKSTRA

Support for immunization access, access to migraine screening. Support for tick-borne disease research and womens health.

Issues related to pharmaceutical manufacturing and development. Issues related to China WRT the BINSA bill.

Tax issues affecting the pharmaceutical industry including international tax; implementation of PL 119-21. Vaccine excise tax issues and VICP.

Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. Issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.

General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21. Legislation and issues related to prior authorization. Issues related to TrumpRX.

Issues related to pharmaceutical manufacturing and development, trade and tariffs; potential tariff actions under Section 232 of the Trade Act of 1962. Issues related to China WRT the BINSA Bill.

Federal legislation regarding land trust issues, government contracting, and general Indian affairs.

Issues related to pharmaceutical manufacturing and development. Issues related to China WRT the BINSA bill.

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 1492 and S. 832. Issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Tax legislation potentially affecting newspapers and their employees. Policies impacting publishing and the news media industry. Provisions related to newspaper pension funding.

Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.

Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.

Drug pricing proposals. Pharmacy Benefit Manager reform proposals. ORPHAN CURES Act, Implementation of IRA, and policy changes including the EPIC Act, Medicaid drug rebate program, Issues related to drug pricing in Medicare Parts B and D; Issues related to Most Favored Nation (MFN) drug pricing proposals.

Drug pricing proposals. Pharmacy Benefit Manager reform proposals, clinical trial reforms, 340B. Vaccine safety and access issues, FDA reforms and changes, drug supply and shortage issues. Issues related to TrumpRX.

Issues related to drug pricing; Issues related to reimbursement of insulin products and obesity medications: Issues related to most favored nation pricing polices.

340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).

International and domestic tax issues. Implementation of PL 119-21.

Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 7468, the First-Time Home Buyer Empowerment Act. Proposals to broaden access for ABLE plans; S. 2459, and H.R. 4644: ABLE Employment Flexibility Act; S. 4498, the ABLE Tomorrow Act; S. 4492, the "ABLE Match Act"; and S. 4493, related to direct deposits into ABLE programs. Implementation of various expansions of 529 plan qualified uses enacted by Congress.

Higher education reauthorization proposals pertaining to college savings. Issues related to Section 529 plans and treatment under FAFSA.

Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues.

Issues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing), access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. P.L. 119-37; aviation issues impacted by government shutdown.

Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. Fiscal Year 2026 Homeland Security Appropriations.

Issues pertaining to J-Visa exchange visitor programs.

Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Issues related to Medicaid, Medicare Advantage, behavioral health and prior authorization.

Issues related to health insurance and affordability.

Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.

General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.

Advocate for policies supporting higher education and access to higher education; higher education compliance and reporting. College Cost Reduction Act, higher education issues related to budget reconciliation. H.R. 1. H.R. 4312. Implementation of education provisions in P.L. 119-21.

NIL proposals and Protect College Sports Act S.4668.

Advocacy for policies impacting education for profoundly gifted students.

Advocacy for policies impacting education for profoundly gifted students.

Advocacy for policies impacting education of profoundly gifted students.

Policies impacting the EB-5 Program. H.R. 1. P.L. 119-37; immigration related policies related to Fiscal Year 2026 government funding legislation.

Support for community hospitals and rural healthcare.

Medicare status; support for small community hospitals and rural healthcare.

Medicare status; support for small community hospitals and rural healthcare. Rural Community Hospital Demonstration Reauthorization Act.

Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals. Issues related to proposed Basel III changes; revised regulations under the Community Reinvestment Act.

Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515. H.R.9012.

Imports, exports and foreign markets; general trade issues and related matters including duties and tariffs. Issues related to Foreign Trade Zones and manufacturing in the U.S. Section 232 of the Trade Expansion Act of 1962 and Section 301 of the Trade Act of 1974; actions, exemptions and exclusions.

Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; implementation of PL 119-21. S. 5552 and H.R. 10582, to provide tax incentives for certain motion picture and TV productions.

Legislation affecting multichannel TV, broadband, telephone, and the Internet, including taxation, intellectual property, spectrum allocation and regulatory issues, state taxation of cable TV and DBS, open Internet/broadband industry practices, data privacy, children's privacy, and rural broadband policies.

Access to autism services for those with Autism Spectrum Disorder in the context of healthcare legislation, and CHIP.

Access to autism services for those with Autism Spectrum Disorder in the context of healthcare legislation, and CHIP.

Information technology legislation; appropriations legislation.

Tax legislation affecting the information technology industry; implementation of PL 119-21. H.R. 8101 and S. 4221, the "Ensuring Better Interest Treatment and Deductibility Act.".

Financial data privacy; cyber security, cyber insurance, data breach legislation. Credit risk transfer. S.3772, Export-Import Bank Reauthorization Act of 2026; H.R.__ Discussion Draft Export-Import Bank Reauthorization Act of 2026.

H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.

Access to autism services for those with Autism Spectrum Disorder in the context of healthcare legislation, and CHIP.

Access to autism services for those with Autism Spectrum Disorder in the context of healthcare legislation, and CHIP.

Information technology legislation; appropriations legislation.

Tax legislation affecting the information technology industry; implementation of PL 119-21. H.R. 8101 and S. 4221, the "Ensuring Better Interest Treatment and Deductibility Act.".

Actions under Section 301 of the Trade Act of 1974, IEEPA, Section 232 of the Trade Expansion Act of 1962, and other trade-related authorities; export control actions and investment control proposals; other trade actions and developments.

International tax provisions relating to multinational corporations; taxation on foreign direct investment; business taxation in general including treatment of debt/equity; and implementation of PL 119-21.

Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.

Trade issues impacting US-based companies.

Cybersecurity and information sharing and cyber threats.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. 340B, Vaccine issues.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Support for obesity drug coverage and access.

Issues related to corporate tax and international tax including related domestic and international tax issues for reconciliation legislation; monitor implementation of PL 119-21.

Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.

Issues related to pharmaceutical manufacturing and development, trade and tariffs; potential tariff actions under Section 232 of the Trade Act of 1962.

General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21.

Federal legislation regarding land trust issues, government contracting, and general Indian affairs.

Issues related to pharmaceutical manufacturing and development.

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 1492 and S. 832. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Tax legislation potentially affecting newspapers and their employees. Policies impacting publishing and the news media industry. Provisions related to newspaper pension funding.

Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.

Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.

Drug pricing proposals. Pharmacy Benefit Manager reform proposals. H.R. 1, "One Big Beautiful Bill Act" implementation and ORPHAN CURES Act, Implementation of IRA, and policy changes including the EPIC Act, Medicaid drug rebate program, Issues related to drug pricing in Medicare Parts B and D; Issues related to Most Favored Nation (MFN) drug pricing proposals.

Drug pricing proposals. Pharmacy Benefit Manager reform proposals, clinical trial reforms, 340B. Vaccine safety and access issues, FDA reforms and changes, drug supply and shortage issues.

Accelerated approval pathway; support for Alzheimer's diagnostics; obesity treatment.

Issues related to pharmaceutical manufacturing and development.

Monitor Issues related to intellectual property protection and market access within current trade negotiations. Section 232 investigations and other tariff issues. Pharmaceutical IP issues, march-in rights.

H.R. 9471, SAFE Banking Act of 2026.

Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 7468, the First-Time Home Buyer Empowerment Act. Proposals to broaden access for ABLE plans; S. 2459, and H.R. 4644: ABLE Employment Flexibility Act; S. 4498, the ABLE Tomorrow Act; S. 4492, the "ABLE Match Act"; and S. 4493, related to direct deposits into ABLE programs. Implementation of various expansions of 529 plan qualified uses enacted by Congress.

Monitoring efforts to onshore and build US pharmaceutical manufacturing capacity.

Monitor progress of next Prescription Drug User Fee Reauthorization, issues relating to US and international manufacturing, oncology issues, FDA reorganization and programs, 340B, monitoring efforts around direct-to-consumer policies.

Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues.

Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. S. 1582.

Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. Fiscal Year 2026 Homeland Security Appropriations.

Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; implementation of PL 119-21.

Legislation affecting multichannel TV, broadband, telephone, and the Internet, including taxation, intellectual property, spectrum allocation and regulatory issues, state taxation of cable TV and DBS, open Internet/broadband industry practices, data privacy, children's privacy, and rural broadband policies.

General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.

General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.

Advocate for policies supporting higher education and access to higher education; higher education compliance and reporting. College Cost Reduction Act, higher education issues related to budget reconciliation. H.R. 1. H.R. 4312. Implementation of education provisions in P.L. 119-21.

Advocacy for policies impacting education for profoundly gifted students.

Advocacy for policies impacting education of profoundly gifted students.

Advocacy for policies impacting education for profoundly gifted students.

Policies impacting the EB-5 Program. H.R. 1. P.L. 119-37; immigration related policies related to Fiscal Year 2026 government funding legislation.

Support for community hospitals and rural healthcare.

Medicare status; support for small community hospitals and rural healthcare. Rural Community Hospital Demonstration Reauthorization Act.

Medicare status; support for small community hospitals and rural healthcare.

Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals.

Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515.

Issues pertaining to J-Visa exchange visitor programs.

Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Issues related to Medicaid, Medicare Advantage, behavioral health and prior authorization.

Issues related to health insurance and affordability.

Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Imports, exports and foreign markets; general trade issues and related matters including duties and tariffs. Issues related to Foreign Trade Zones and manufacturing in the U.S. Section 232 of the Trade Expansion Act of 1962 and Section 301 of the Trade Act of 1974; actions, exemptions and exclusions.

H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.

Financial data privacy; cyber security, cyber insurance, data breach legislation. Credit risk transfer. S.3772, Export-Import Bank Reauthorization Act of 2026; H.R.__ Discussion Draft Export-Import Bank Reauthorization Act of 2026.

Access to autism services for those with Autism Spectrum Disorder in the context of healthcare legislation, and CHIP.

Access to autism services for those with Autism Spectrum Disorder in the context of healthcare legislation, and CHIP.

Tax legislation affecting the information technology industry; implementation of PL 119-21. H.R. 8101 and S. 4221, the "Ensuring Better Interest Treatment and Deductibility Act.".

Information technology legislation; appropriations legislation.

General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.

General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.

Advocate for policies supporting higher education and access to higher education; higher education compliance and reporting. College Cost Reduction Act, higher education issues related to budget reconciliation. H.R. 1. H.R. 4312. Implementation of education provisions in P.L. 119-21.

Advocacy for policies impacting education for profoundly gifted students.

Advocacy for policies impacting education of profoundly gifted students.

Advocacy for policies impacting education for profoundly gifted students.

Policies impacting the EB-5 Program. H.R. 1. P.L. 119-37; immigration related policies related to Fiscal Year 2026 government funding legislation.

Support for community hospitals and rural healthcare.

Medicare status; support for small community hospitals and rural healthcare.

Medicare status; support for small community hospitals and rural healthcare.

Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century Road to Housing Act; build to rent housing proposals.

Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515.

Actions under Section 301 of the Trade Act of 1974, IEEPA, Section 232 of the Trade Expansion Act of 1962, and other trade-related authorities; export control actions and investment control proposals; other trade actions and developments.

International tax provisions relating to multinational corporations; taxation on foreign direct investment; business taxation in general including treatment of debt/equity; and implementation of PL 119-21.

Trade issues impacting US-based companies.

Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. 340B, Vaccine issues.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Issues related to corporate tax and international tax including related domestic and international tax issues for reconciliation legislation; monitor implementation of PL 119-21.

Support for obesity drug coverage and access.

Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Support for immunization access, access to migraine screening. Support for tick-borne disease research and womens health.

General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21.

Issues related to pharmaceutical manufacturing and development.

Federal legislation regarding land trust issues, government contracting, and general Indian affairs.

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 1492 and S. 832.

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 1492 and S. 832. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Tax legislation potentially affecting newspapers and their employees. Policies impacting publishing and the news media industry. Provisions related to newspaper pension funding.

Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.

Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.

Drug pricing proposals. Pharmacy Benefit Manager reform proposals. H.R. 1, "One Big Beautiful Bill Act" implementation and ORPHAN CURES Act, Implementation of IRA, and policy changes including the EPIC Act, Medicaid drug rebate program, Issues related to drug pricing in Medicare Parts B and D; Issues related to Most Favored Nation (MFN) drug pricing proposals.

Drug pricing proposals. Pharmacy Benefit Manager reform proposals, clinical trial reforms, 340B. Vaccine safety and access issues, FDA reforms and changes, drug supply and shortage issues.

Outreach on renewable energy project in Taoyuan City, Taiwan; U.S. International Development Finance Corporation which is not an option in the drop down box.

Issues related to pharmaceutical manufacturing and development.

Monitor Issues related to intellectual property protection and market access within current trade negotiations. Section 232 investigations and other tariff issues. Pharmaceutical IP issues, march-in rights.

Drug importation, prescription drug safety, value and access.

Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529. Proposals to broaden access for ABLE plans; S. 2459, and H.R. 4644: ABLE Employment Flexibility Act. Implementation of various expansions of 529 plan qualified uses enacted by Congress.

Higher education reauthorization proposals pertaining to college savings. Issues related to Section 529 plans and treatment under FAFSA. H.R. 1, One Big Beautiful Bill Act.

Monitor progress of next Prescription Drug User Fee Reauthorization, issues relating to US and international manufacturing, oncology issues, FDA reorganization and programs, 340B, monitoring efforts around direct-to-consumer policies.

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Monitoring efforts to onshore and build US pharmaceutical manufacturing capacity.

Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security.

Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. P.L. 119-37; aviation issues impacted by government shutdown.

Legislation affecting multichannel TV, broadband, telephone, and the Internet, including taxation, intellectual property, spectrum allocation and regulatory issues, state taxation of cable TV and DBS, open Internet/broadband industry practices, data privacy and children's privacy, and rural broadband policies.

Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; implementation of PL 119-21.

Issues pertaining to J-Visa exchange visitor programs.

Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).

Issues related to Advance Premium Tax Credits (APTCs) and cost-sharing reductions.

Issues related to Medicaid, Medicare Advantage, behavioral health and prior authorization.

Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).